Silver Book Fact

In 2010, ~67,500 SAVRs were performed in the U.S.

Fact image

Clark M, Duhay F, Thompson A, et al. Clinical and Economic Outcomes After Surgical Aortic Valve Replacement in Medicare Patients. Risk Manag Healthc Policy. 2012; 2012(5). https://www.dovepress.com/clinical-and-economic-outcomes-after-surgical-aortic-valve-replacement-peer-reviewed-article-RMHP

Reference

Title
Clinical and Economic Outcomes After Surgical Aortic Valve Replacement in Medicare Patients
Publication
Risk Manag Healthc Policy
Publication Date
2012
Authors
Clark M, Duhay F, Thompson A, et al
Volume & Issue
Volume 2012, Issue 5
Pages
117-26
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…  
  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…  
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Improvements in QoL from TAVR in SAS patients
    Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state)…  
  • Survival rates of SAS patients ages 80+ with and without SAVR